|
|
|
Volumn 15, Issue 3, 1995, Pages 387-393
|
|
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT
a
a
a
a
a
a
a
a
a
|
|
Author keywords
CMV infection; T cell depletion; Transplantation
|
|
Indexed keywords
ALEMTUZUMAB;
CD8 ANTIGEN;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
METHOTREXATE;
ADOLESCENT;
ADULT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ARTICLE;
CLINICAL TRIAL;
CYTOMEGALOVIRUS INFECTION;
FEMALE;
GRAFT VERSUS HOST REACTION;
HUMAN;
IMMUNE RESPONSE;
IMMUNOSUPPRESSIVE TREATMENT;
INTERMETHOD COMPARISON;
INTERSTITIAL PNEUMONIA;
INTRAVENOUS DRUG ADMINISTRATION;
LYMPHOCYTE COUNT;
MAJOR CLINICAL STUDY;
MALE;
NATURAL KILLER CELL;
PRIORITY JOURNAL;
T LYMPHOCYTE;
VIRUS SHEDDING;
ADOLESCENT;
ADULT;
BONE MARROW TRANSPLANTATION;
CYCLOSPORINE;
CYTOMEGALOVIRUS INFECTIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT VS HOST DISEASE;
HUMAN;
INCIDENCE;
LYMPHOCYTE DEPLETION;
LYMPHOCYTOSIS;
MALE;
METHOTREXATE;
MIDDLE AGE;
PNEUMONIA, VIRAL;
SUPPORT, NON-U.S. GOV'T;
T-LYMPHOCYTES;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0028946632
PISSN: 02683369
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (62)
|
|
References (0)
|
